Denali Therapeutics Inc
(BSP:D2NL34)
R$
27.06
(0%)
Market Cap: 20.67 Bil
Enterprise Value: 17.15 Bil
PE Ratio: 0
PB Ratio: 4.91
GF Score: 6/100 Denali Therapeutics Inc (BSP:D2NL34) Transcripts
- 1